![International Alzheimer's clinical trial to test tau drugs – Washington University School of Medicine in St. Louis International Alzheimer's clinical trial to test tau drugs – Washington University School of Medicine in St. Louis](https://medicine.wustl.edu/wp-content/uploads/20181010_MM_Bateman136_forweb.jpg)
International Alzheimer's clinical trial to test tau drugs – Washington University School of Medicine in St. Louis
![An update on clinical trials targeting human tauopathies Javidnia M, Kurd-Misto BT, Moussa CE - Clin Trials Degener Dis An update on clinical trials targeting human tauopathies Javidnia M, Kurd-Misto BT, Moussa CE - Clin Trials Degener Dis](https://www.clinicaltdd.com/articles/2017/2/3/images/ClinTranslDegenerDis_2017_2_3_66_216580_t4.jpg)
An update on clinical trials targeting human tauopathies Javidnia M, Kurd-Misto BT, Moussa CE - Clin Trials Degener Dis
![Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial - The Lancet Neurology Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2105768073/2081271563/gr1.gif)
Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial - The Lancet Neurology
![Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial - The Lancet Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/be24fa2c-e100-4cbc-aecc-351856a3fbf2/gr1_lrg.gif)
Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial - The Lancet
![ANTI-TAU TRIALS FOR ALZHEIMER'S DISEASE: A REPORT FROM THE EU/US/CTAD TASK FORCE • The Journal of Prevention of Alzheimer's Disease ANTI-TAU TRIALS FOR ALZHEIMER'S DISEASE: A REPORT FROM THE EU/US/CTAD TASK FORCE • The Journal of Prevention of Alzheimer's Disease](https://www.jpreventionalzheimer.com/wp-content/uploads/2019/04/FIG-1-CUMMINGS.gif)
ANTI-TAU TRIALS FOR ALZHEIMER'S DISEASE: A REPORT FROM THE EU/US/CTAD TASK FORCE • The Journal of Prevention of Alzheimer's Disease
![PDF] Tau Protein-Targeted Therapies in Alzheimer's Disease: Current State and Future Perspectives | Semantic Scholar PDF] Tau Protein-Targeted Therapies in Alzheimer's Disease: Current State and Future Perspectives | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d0b824259b25173e952c07d0978554f9e20554dc/7-Table1-1.png)
PDF] Tau Protein-Targeted Therapies in Alzheimer's Disease: Current State and Future Perspectives | Semantic Scholar
![Agents in clinical trials for treatment of Alzheimer's disease in 2018... | Download Scientific Diagram Agents in clinical trials for treatment of Alzheimer's disease in 2018... | Download Scientific Diagram](https://www.researchgate.net/publication/324936192/figure/fig1/AS:643259705589760@1530376473701/Agents-in-clinical-trials-for-treatment-of-Alzheimers-disease-in-2018-from.png)
Agents in clinical trials for treatment of Alzheimer's disease in 2018... | Download Scientific Diagram
![טוויטר \ Brain בטוויטר: "Is longitudinal tau PET ready for use in Alzheimer's disease clinical trials? New scientific commentary by Oskar Hansson & Elizabeth Mormino https://t.co/TL15nBupsu; https://t.co/ekb1snc064 https://t.co/0Gz1W3nYEs" טוויטר \ Brain בטוויטר: "Is longitudinal tau PET ready for use in Alzheimer's disease clinical trials? New scientific commentary by Oskar Hansson & Elizabeth Mormino https://t.co/TL15nBupsu; https://t.co/ekb1snc064 https://t.co/0Gz1W3nYEs"](https://pbs.twimg.com/media/DcDhVAUXUAEo5zv.jpg:large)